Understanding how posttranscriptional regulatory networks affect Ebola virus disease.
Research Project 2: Role of Posttranscriptional Regulatory Networks in the Pathogenesis of Ebola Virus Disease
['FUNDING_P01'] · UNIVERSITY OF TEXAS MED BR GALVESTON · NIH-11105948
This study is looking at how the Ebola virus affects the body after it enters cells, hoping to find new ways to treat the disease and help patients feel better.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS MED BR GALVESTON (nih funded) |
| Locations | 1 site (GALVESTON, UNITED STATES) |
| Trial ID | NIH-11105948 on ClinicalTrials.gov |
What this research studies
This research investigates the complex interactions of regulatory networks that occur after transcription in the context of Ebola virus disease. By analyzing how these networks influence the virus's behavior and the host's response, the research aims to uncover critical mechanisms that contribute to the disease's pathogenesis. The approach includes advanced molecular biology techniques to study gene expression and regulation in infected cells, which could lead to new insights into treatment strategies. Patients may benefit from a deeper understanding of the disease, potentially leading to improved therapeutic options.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit would include individuals at risk of Ebola virus exposure or those affected by the disease.
Not a fit: Patients with other viral infections or unrelated health conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating or preventing Ebola virus disease.
How similar studies have performed: While research on Ebola has been conducted, the specific focus on posttranscriptional regulatory networks is a novel approach that has not been extensively tested.
Where this research is happening
GALVESTON, UNITED STATES
- UNIVERSITY OF TEXAS MED BR GALVESTON — GALVESTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BUKREYEV, ALEXANDER — UNIVERSITY OF TEXAS MED BR GALVESTON
- Study coordinator: BUKREYEV, ALEXANDER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.